HFA suspension formulations containing an anticholinergic

作者: Christel Schmelzer

DOI:

关键词:

摘要: The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate (1α,2β,4β,5α,7β)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0 2,4 ]nonane-bromide.

参考文章(29)
Michael Trunk, Peter Specht, Christian Kulinna, Peter Sieger, Helmut Meissner, Andreas Mathes, Manfred Ludwig August Graulich, Rolf Banholzer, Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament ,(2001)
Stephen Byrn, Ralph Pfeiffer, Michael Ganey, Charles Hoiberg, Guirag Poochikian, Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations Pharmaceutical Research. ,vol. 12, pp. 945- 954 ,(1995) , 10.1023/A:1016241927429
Rudolf Bauer, Werner Schulz, Rolf Banholzer, Alex Heusner, Quaternary N-β-substituted N-alkyl-nortropine benzilates ,(1976)
Sven Luettke, Peter Specht, Manfred Graulich, Wolfgang Broeder, Helmut Meissner, Andreas Mathes, Rolf Banholzer, Process for preparing a scopine ester intermediate ,(2002)
Christel Schmelzer, Michael Paul Pieper, Michel Pairet, Christopher John Montague Meade, Richard Reichl, Pharmaceutical compositions based on anticholinergics and corticosteroids ,(2001)
Brian Charles GlaxoSmithKline Gavin, Medical combinations comprising tiotropium and rofleponide ,(2001)
Christel Schmelzer, Michael Paul Pieper, Michel Pairet, Christopher John Montague Meade, Richard Reichl, Novel medicament compositions based on anticholinergics and corticosteroids ,(2001)